Abstract B29: Anti-breast cancer effects of the Vav/Rac inhibitor Ehop-016 in the tumor microenvironment
This study was supported by National Institute on Minority Health and Health Disparities of the National Institutes of Health (NIMHHD/NIH) U54MD008149 and the Puerto Rico Science and Technology Trust to SD; Title V PPOHA P031M10505 and Title V Cooperative P031S130068 from U.S. Department of Education, and RCMI 8G12MD007583 to UCC; and UPR RCM NIH/NIMHHD grants 5U54CA096297 andR25GM061838 to THB.Citation Format: Linette Castillo-Pichardo, Cristina Del Valle, Jessica Morales, Valance Washington, Krizia Rohena-Rivera, Magaly Martinez, Luis Cubano, Suranganie Dharmawardhane. Anti-breast cancer effects of the Vav/Rac inhibitor Ehop-016 in the tumor microenvironment. [abstract]. In: Proceedings of the AACR Special Conference on Advances in Breast Cancer Research; Oct 17-20, 2015; Bellevue, WA. Philadelphia (PA): AACR; Mol Cancer Res 2016;14(2_Suppl):Abstract nr B29.
Source: Molecular Cancer Research - Category: Cancer & Oncology Authors: Castillo-Pichardo, L., Valle, C. D., Morales, J., Washington, V., Rohena-Rivera, K., Martinez, M., Cubano, L., Dharmawardhane, S. Tags: Targeted Therapies: Poster Presentations - Proffered Abstracts Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Conferences | Education | Grants | Health | National Institutes of Health (NIH) | Science | Statistics | Study | Universities & Medical Training